Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Aya Ahmed Nasser
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Female patients aged \\ge 18 years old., Histologically confirmed advanced epithelial ovarian cancer (High-Grade Serous Ovarian Carcinoma), Stage III or IV.
Patients who received platinum-based neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) at Sohag University Hospital or Sohag Cancer Center between 2022 and 2025.
Available complete medical records, including pre-treatment baseline CBC (for NLR and PLR calculation) and longitudinal CA-125 levels (for KELIM score estimation).
You may not be if
Patients with non-epithelial ovarian tumors (e.g., germ cell tumors, sex cord-stromal tumors).
Patients who underwent primary debulking surgery (PDS) before receiving chemotherapy.
Patients with concurrent active malignancies or a history of other cancers within the past 5 years.
Patients with active systemic inflammatory diseases, hematological disorders, or severe infections at baseline that could interfere with baseline inflammatory markers (NLR/PLR).
Incomplete or missing clinical, surgical, or follow-up data.
